LifeStance Therapists & Psychiatrists Savannah
635 Stephenson Avenue, Suite B, Savannah
4.1(327 Google reviews)
United States
8 listed treatment centers serving Savannah and the surrounding area.
635 Stephenson Avenue, Suite B, Savannah
4.1(327 Google reviews)
4849 Paulsen Street, Suites 102 & 209, Savannah
4.4(315 Google reviews)
For people in Savannah considering SPRAVATO®, the total cost can involve both the medication and the visit for supervised administration and monitoring. These services may be billed separately. Before scheduling, ask the treatment center for a written estimate explaining what it includes and what you could owe under your insurance benefits.
Coverage varies by plan. Prior authorization is common, and your insurer may require documentation of earlier antidepressant trials. Ask your prescribing clinician to help gather medication names, doses, treatment dates, and information about your response or side effects. The center can explain what records it needs and who submits the authorization request. An authorization does not necessarily mean every charge is covered.
Medicare coverage may fall under Part B or Part D depending on the plan and treatment setting. Georgia Medicaid coverage also depends on the applicable plan and setting. Neither general program coverage nor a directory listing establishes that a particular center accepts your insurance. Confirm participation directly with both the center and your insurer.
Manufacturer savings programs exist for eligible commercially insured patients, but not for patients using government insurance. Ask about current eligibility rules and which expenses assistance may address; do not assume it covers the entire visit.
Before starting, ask:
SPRAVATO® treatment requires repeated visits to a SPRAVATO® REMS-certified healthcare setting. You self-administer the nasal spray under direct observation of a healthcare provider; it is never sent home for use. A directory listing alone does not verify certification, so confirm the location's current REMS status before scheduling.
The typical labeled schedule begins with twice-weekly visits during weeks 1–4, followed by weekly visits during weeks 5–8. Maintenance visits may then be weekly or every two weeks. Your prescriber individualizes the schedule, so use this as a planning guide rather than a promise about your treatment.
Allow at least two hours for monitoring after each dose, plus time for check-in, preparation, and discharge assessment. Ask the center how much time to reserve overall. If you work, discuss recurring appointment blocks or time off early, and avoid planning to drive or operate machinery afterward.
Arrange for someone else to take you home after every appointment. You must not drive until the next day after a restful sleep. A family member, friend, or other driver may help; ask the center about its pickup and accompaniment requirements before relying on a hired ride. Having a backup ride can help prevent disruptions.
If you cannot find a listed Savannah center when searching, or listed locations cannot accommodate you, expand your search to Richmond Hill. Other Georgia cities with listings include Atlanta, Johns Creek, and Augusta-Richmond County. Listings do not establish availability or certification. Before planning travel, confirm new-patient access, insurance participation, visit frequency, and whether repeated trips are practical.
Use Savannah directory listings as a starting point, then contact the location to confirm that it currently provides SPRAVATO® and is REMS-certified. Certification has not been verified in the supplied listings. Ask whether the center accepts new patients, what referral or records it needs, and whether it participates in your insurance. If local options do not work out, Richmond Hill is another city with a listed option to investigate.
Spravato is approved for adults with treatment-resistant depression, either alone or with an oral antidepressant. It is also approved for depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior, together with an oral antidepressant. It is not approved for children. A clinician must review your symptoms, treatment history, and health risks to determine whether it is appropriate; a diagnosis alone does not guarantee eligibility.
Coverage depends on your plan, the treatment setting, and authorization requirements. Insurers commonly request records of previous antidepressant trials. Ask about coverage for both the medication and the supervised monitoring visit. Medicare and Georgia Medicaid may cover treatment depending on the plan and setting, but you must separately confirm that a center accepts your coverage. Request an estimate of your responsibility before starting.
You use the nasal spray yourself while a healthcare provider directly observes you in a REMS-certified setting. After each dose, staff monitor you for at least two hours, including for sedation, dissociation, breathing problems, and blood pressure increases. Discharge depends on the provider's assessment, not simply the clock. You cannot take doses home, and you need someone else to take you home after the visit.
Important risks include sedation, dissociation, respiratory depression, and increased blood pressure. Dissociation can feel like being disconnected from yourself or your surroundings. Spravato carries boxed warnings for sedation, dissociation, respiratory depression, abuse and misuse, and suicidal thoughts and behaviors. It is a Schedule III controlled substance. Review your health history and medications with your clinician, and tell staff promptly about symptoms during monitoring.
No. Do not drive or operate machinery until the next day after a restful sleep, even if you feel ready sooner. Arrange a driver for every visit and check the center's rules about pickup and accompaniment. For Savannah appointments, plan work and household responsibilities around the visit and driving restriction. Keep a backup transportation plan in case your usual driver becomes unavailable.
No. Spravato has not been shown to prevent suicide or reduce suicidal thoughts or behavior, and it does not replace hospitalization when clinically needed. Its approval for depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior requires use with an oral antidepressant. Do not wait for a treatment appointment in a crisis: call or text 988, or call 911 in an emergency.
Approved uses, nearby treatment centers, and medically sourced patient guides.